BBIO · BridgeBio Pharma, Inc.

$79.86 -1.35 (-1.66%) At close · Aug 14

Market Cap

$15.61B

195.49M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
10-Q	2026-08-10	2026-06-30
8-K	2026-08-10	—
8-K	2026-07-22	—
8-K	2026-07-02	2026-07-01
8-K	2026-06-26	2026-06-22
Investor Event Transcript	2026-06-09	2026-06-30
Investor Event Transcript	2026-06-04	2026-06-30
8-K	2026-05-27	—
8-K	2026-05-13	2026-05-12
8-K	2026-05-08	2026-05-07
8-K	2026-05-07	2026-05-06
10-Q	2026-05-07	2026-03-31
DEF 14A	2026-04-24	2026-06-22
Investor Event Transcript	2026-03-31	—
Investor Event Transcript	2026-03-31	—
8-K	2026-03-30	—
10-K	2026-02-24	2025-12-31
8-K	2026-02-24	—
8-K	2026-02-12	—
8-K	2026-01-21	2026-01-14
8-K	2026-01-12	—
Investor Event Transcript	2025-12-31	—
Investor Event Transcript	2025-12-31	—
8-K	2025-10-29	—
8-K	2025-10-29	—
10-Q	2025-10-29	2025-09-30
8-K	2025-10-27	—
10-Q	2025-08-05	2025-06-30
8-K	2025-08-05	—
8-K	2025-07-02	2025-06-27
8-K	2025-06-23	2025-06-20
DEF 14A	2025-04-30	2025-06-20
10-Q	2025-04-29	2025-03-31
8-K	2025-04-29	—
8-K	2025-03-17	—
8-K	2025-02-28	2025-02-24
10-K	2025-02-20	2024-12-31
8-K	2025-02-20	—
8-K	2025-01-13	—
8-K	2024-11-25	2024-11-22
8-K	2024-11-12	—
10-Q	2024-11-12	2024-09-30
8-K	2024-09-11	2024-09-10
8-K	2024-08-21	2024-08-16
8-K	2024-08-01	—
10-Q	2024-08-01	2024-06-30
8-K	2024-07-23	—
8-K	2024-06-24	2024-06-21
8-K	2024-06-06	2024-06-04
10-Q	2024-05-02	2024-03-31

Showing 1–50 of 138 filings

Key facts CIK 1743881 CUSIP 10806X102 13F (30d) 438 filings 433 filers Visit website Investor relations